日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groups

肿瘤学领域的真实世界数据：一项基于问卷调查的学术研究现状分析，旨在考察癌症合作组的政策和经验

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.100878
Saesen, R; Lacombe, D; Huys, I
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Patients' knowledge, preferences, and perspectives about data protection and data control: an exploratory survey

患者对数据保护和数据控制的认知、偏好和看法：一项探索性调查

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1280173
Lalova-Spinks, Teodora; Saesen, Robbe; Silva, Mitchell; Geissler, Jan; Shakhnenko, Iryna; Camaradou, Jennifer Catherine; Huys, Isabelle
神经科学
发表日期：2023
文献求助 收藏

Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments

分析实用主义抗肿瘤治疗试验的特征和实用主义程度

期刊:BMC Medical Research Methodology
影响因子:3.4
doi:10.1186/s12874-023-01975-9
Saesen, Robbe; Depreytere, Kevin; Krupianskaya, Karyna; Langeweg, Joël; Verheecke, Julie; Lacombe, Denis; Huys, Isabelle
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators

欧洲药品管理局参与多方利益相关者监管科学研究项目：工作人员和项目协调员的经验

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1181702
Saesen, Robbe; Machado, Matilde; Crifo, Bianca; Liu, Lifang; de Vries, Corinne; Herold, Ralf; Llinares Garcia, Jordi; Huys, Isabelle
发表日期：2023
文献求助 收藏

How to balance valuable innovation with affordable access to medicines in Belgium?

如何在比利时实现有价值的创新与药品价格可承受性之间取得平衡？

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.960701
Simoens, Steven; Abdallah, Khadidja; Barbier, Liese; Lacosta, Teresa Barcina; Blonda, Alessandra; Car, Elif; Claessens, Zilke; Desmet, Thomas; De Sutter, Evelien; Govaerts, Laurenz; Janssens, Rosanne; Lalova, Teodora; Moorkens, Evelien; Saesen, Robbe; Schoefs, Elise; Vandenplas, Yannick; Van Overbeeke, Eline; Verbaanderd, Ciska; Huys, Isabelle
发表日期：2022
文献求助 收藏

Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders

罕见癌症早期临床试验的特点：来自利益相关者访谈的见解

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.775217
Dooms, M; Saesen, R; Steemans, I; Lansens, J; Huys, I
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer

过去、现在和未来的癌症临床研究合作：以欧洲癌症研究与治疗组织为例

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.12863
Broes, Stefanie; Saesen, Robbe; Lacombe, Denis; Huys, Isabelle
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

欧洲药物研发利益相关者对治疗优化及其在决策中应用潜力的看法

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2020.00043
Saesen, Robbe; Lejeune, Stéphane; Quaglio, Gianluca; Lacombe, Denis; Huys, Isabelle
发表日期：2020
文献求助 收藏